Genomics: success or failure to deliver drug targets?
- 31 August 2005
- journal article
- review article
- Published by Elsevier in Current Opinion in Chemical Biology
- Vol. 9 (4) , 387-391
- https://doi.org/10.1016/j.cbpa.2005.05.001
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- High-Throughput RNA Interference Strategies for Target Discovery and Validation by Using Synthetic Short Interfering RNAs: Functional Genomics Investigations of Biological PathwaysPublished by Elsevier ,2005
- The promise of genomics to identify novel therapeutic targetsEmerging Therapeutic Targets, 2004
- Finishing the euchromatic sequence of the human genomeNature, 2004
- The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and strokeNature Genetics, 2004
- Localization of a Susceptibility Gene for Type 2 Diabetes to Chromosome 5q34–q35.2American Journal of Human Genetics, 2003
- Adenoviral Vectors Expressing siRNAs for Discovery and Validation of Gene FunctionGenome Research, 2003
- Knockouts model the 100 best-selling drugs—will they model the next 100?Nature Reviews Drug Discovery, 2003
- The druggable genomeNature Reviews Drug Discovery, 2002
- The Sequence of the Human GenomeScience, 2001
- Initial sequencing and analysis of the human genomeNature, 2001